A
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- 8-K34.0 KBAlexza Pharmaceuticals Inc.Jul 1, 4:34 PM ET·0001193125-16-640542
- 8-K49.6 KBAlexza Pharmaceuticals Inc.Jun 24, 4:06 PM ET·0001193125-16-631522
- 46.9 KBAlexza Pharmaceuticals Inc.Jun 22, 3:12 PM ET·0001209191-16-129191
- 421.3 KBAlexza Pharmaceuticals Inc.Jun 21, 3:56 PM ET·0001209191-16-129018
- 425.3 KBAlexza Pharmaceuticals Inc.Jun 21, 3:54 PM ET·0001209191-16-129014
- 418.5 KBAlexza Pharmaceuticals Inc.Jun 21, 3:52 PM ET·0001209191-16-129011
- 425.4 KBAlexza Pharmaceuticals Inc.Jun 21, 3:50 PM ET·0001209191-16-129007
- 428.5 KBAlexza Pharmaceuticals Inc.Jun 21, 3:47 PM ET·0001209191-16-129004
- 425.1 KBAlexza Pharmaceuticals Inc.Jun 21, 3:45 PM ET·0001209191-16-129000
- 427.6 KBAlexza Pharmaceuticals Inc.Jun 21, 3:42 PM ET·0001209191-16-128996
Insiders
10- Barron HalDirector
- BUCHI J KEVINDirector
- BUSSER ANDREW LDirector
- Cassella James VSVP, Research & Development
- COLELLA SAMUEL DDirector
- FRAZIER ALAN DDirector
- KESSEL MARK10% Owner, See Footnote 2 and Remarks
- KING THOMAS BRAXTONDirector, Pres & CEO
- LANSDOWNE PARTNERS AUSTRIA GMBH10% Owner
- Lippe Robert AEVP, Operations & COO
Tickers
No tickers on record
Addresses
business
2091 STIERLIN COURT
MOUNTAIN VIEW, CA, 94043
mailing
2091 STIERLIN COURT
MOUNTAIN VIEW, CA, 94043